EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER
Saadettin KılıçkapABSTRACT
cell lung cancer (NSCLC). Mutation of EGFR occurs in 15-40% of all patients with NSCLC. In this review, efficacy of different EGFR inhibitors used in NSCLC treatment is evaluated.
Authors Orcid Profiles
Article Details
EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER
05-08Saadettin Kılıçkap
REVIEW Nobel Med 2018; 14(3): 5-8EMOTIONAL INTELLIGENCE CAPABILITIES AND PROFESSIONALISM BEHAVIORS OF NURSES IN PUBLIC HOSPITALS IN BURSA PROVINCE
09-18Derya Aslan, Halim İşsever
RESEARCH ARTICLE Nobel Med 2018; 14(3): 9-18THE PREVALENCE OF METABOLIC SYNDROME AND RELATED FACTORS
19-24Ferda Özyurda, Nazlı Atak
RESEARCH ARTICLE Nobel Med 2018; 14(3): 19-24EFFECT OF HYDATID DISEASE ON BODY COMPOSITION AS ASSESSED BY BIOELECTRICAL IMPEDANCE ANALYSIS
25-30Muazez Çevik, Cemil Sert
RESEARCH ARTICLE Nobel Med 2018; 14(3): 25-30THE RELATIONSHIP OF SPORT, STRESS, ANXIETY AND DEPRESSION: PRELIMINARY STUDY
31-38Arkun Tatar, Melek Astar, Ebru Turhan
RESEARCH ARTICLE Nobel Med 2018; 14(3): 31-38SERUM S100B LEVELS IN PATIENTS WITH MAJOR DEPRESSION AND PANIC DISORDER
39-44Hakan Ayyıldız, Nezaket Eren, Berna Aslan, Fatma Turgay, Şebnem Ciğerli, Oğuz Karamustafalıoğlu, Gökay Alpak
RESEARCH ARTICLE Nobel Med 2018; 14(3): 39-44ATRIO-OESOPHAGEAL FISTULA COMPLICATING CRYOBALLOON WHICH PRESENTED WITH RECURRENT FEVER AND STROKE
45-50Yaşar Küçükardalı, Sina Ercan, Sibel Temur, Burcu Örmeci, Rahman Nurmuhammedov, Olcay Özveren, Mustafa Şimşek, Emine Sevda Özdoğan, Neslihan Taşdelen, Ayşegül Sarsılmaz, Baki Ekci, Meral Sönmezoğlu, Soner Sanioglu, Meltem Ergun
REPORT Nobel Med 2018; 14(3): 45-50PROF. DR. MELİHA TERZİOĞLU (1915-1995) Türkiye’de Fizyoloji Alanına Kazandırdıklarıyla “Yirminci Yüzyılın Önde Gelen Kadınları”ndan
51-56Gamze Nesipoğlu
A PORTRAIT Nobel Med 2018; 14(3): 51-56LIVER AND SYSTEMIC DISEASES
05-09Sebati Özdemir
REVIEW Nobel Med 2013; 9(2): 5-9AGING KIDNEY: SENESCENCE OR DISEASE?
10-14Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk
REVIEW Nobel Med 2013; 9(2): 10-14IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS
15-20Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş
RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
21-25Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan
RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK
26-31Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı
RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT
32-37Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir
RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37REOPERATIONS AND MORBIDITY IN THYROID SURGERY
38-42Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin
RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY
43-46İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun
RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY
47-51İbak Gönen
RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES
52-56Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu
RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56-
Pubmed Style
Saadettin Kılıçkap. [KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ TEDAVİSİNDE EPİDERMAL BÜYÜME FAKTÖR RESEPTÖR İNHİBİTÖRLERİ]. Nobel Med 2018; 14(3): 5-8, Turkish. -
Web Style
Saadettin Kılıçkap. [KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ TEDAVİSİNDE EPİDERMAL BÜYÜME FAKTÖR RESEPTÖR İNHİBİTÖRLERİ]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], Turkish. -
AMA (American Medical Association) Style
Saadettin Kılıçkap. [KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ TEDAVİSİNDE EPİDERMAL BÜYÜME FAKTÖR RESEPTÖR İNHİBİTÖRLERİ]. Nobel Med 2018; 14(3): 5-8, Turkish. -
Vancouver/ICMJE Style
Saadettin Kılıçkap. [KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ TEDAVİSİNDE EPİDERMAL BÜYÜME FAKTÖR RESEPTÖR İNHİBİTÖRLERİ]. Nobel Med (2018); 14(3): 5-8, [cited Mayıs 24, 2021], Turkish. -
Harvard Style
Saadettin Kılıçkap. (2018) [KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ TEDAVİSİNDE EPİDERMAL BÜYÜME FAKTÖR RESEPTÖR İNHİBİTÖRLERİ]. Nobel Med, 14(3): 5-8, Turkish.